 |
| Purchase Information |
| Use this form to request purchase information on ASTM online subscriptions. |
|
 |
Document ASTM E 1873 is offered by IHS as part of an online subscription. This subscription contains many documents on the same topic.
You may also purchase this document alone from the IHS Standards Store.
ASTM E 1873 Document Information:
Title
Standard Guide for Detection of Nucleic Acid Sequences by the Polymerase Chain Reaction Technique
ASTM International
Publication Date:
Nov 1, 2006
Scope:
This guide covers guidelines, recommendations, basic considerations, criteria, and principles to be employed when developing, utilizing, or assessing PCR procedures and specific protocols for the amplification and detection of nucleic acid sequences. This guide is not intended to be a standard procedure with a list of requirements for PCR detection of nucleic acids. This guide is intended to provide information that will assist the user in obtaining quality and reliable data.
Nucleic acid targets for PCR include DNA, as well as RNA; RNA sequences are suitable targets for PCR following reverse transcription of the RNA to complementary DNA (cDNA). This type of amplification technique is known as reverse transcription-PCR (RT-PCR).
This guide has been developed for use in any molecular biology/biotechnology laboratory. This includes, but is not limited to, laboratories that specialize in the diagnosis of human, animal, plant, or bacterial diseases.
This guide conveys the general procedural terminology of PCR technology used for the detection of nucleic acids.
This guide is general; it does not cover the additional guidance that would be needed for specific applications, for example, for the PCR detection of nucleic acid sequences of specific microorganisms.
This guide does not cover details of the various methods that can be utilized to identify PCR-amplified DNA sequences.
This guide does not cover specific variations of the basic PCR or RT-PCR technology (for example, quantitative PCR, real-time PCR, multiplex PCR, and in situ PCR), and it does not cover details of instrument calibration.
Warning—Laboratory work involving certain clinical specimens and microorganisms can be hazardous to personnel.
Warning—Biosafety level 2 (or higher) facilities are recommended for biohazard work (8). Safety guidelines should be adhered to in accordance with CLSI M29-A2 and other recommendations (8).
Keywords:
- DNA probe
- PCR
- primer
- hybridization
- amplification
- diagnosis
- polymerase chain reaction
About IHS
IHS (NYSE: IHS) is a leading global provider of critical technical information, decision-support tools and related services in a number of industries including aerospace and defense, automotive, construction, electronics, and energy. IHS serves customers ranging from large governments and multinational corporations to smaller companies and technical professionals in more than 100 countries. IHS been in business for more than 45 years and employ more than 2,300 people around the world.